Chair in Cognitive Neurology and Innovation Director Kimel Family Centre for Brain Health and Wellness, Baycrest Centre
Director Clinical Trials Unit, Baycrest Centre
Clinical Advisor Centre for Aging + Brain Health Innovation, Baycrest Centre
Dr. Howard Chertkow is a remarkably distinguished cognitive neurologist whose contributions are admired across the world. Dr. Chertkow joins Baycrest and the University of Toronto from Montreal’s McGill University, where he served as Director of the Jewish General Hospital (JGH) and McGill University Bloomfield Centre for Research in Aging and was a Senior Investigator in the Lady Davis Institute for Medical Research. In his practice at the JGH, Dr. Chertkow diagnosed and treated patients with early stage Alzheimer’s disease and other dementias, and helped found and direct Canada’s largest memory clinic.
Dr. Chertkow will direct the new Kimel Family Centre for Brain Health and Wellness, a research, education and clinical interdisciplinary program to develop and evaluate the most promising approaches to preventing cognitive decline. As its inaugural Director, Dr. Chertkow will assemble a state-of-the-art Clinical Trials Unit and further develop Baycrest’s translational research program in dementia to test the latest emerging therapies for Alzheimer’s disease and related conditions. He will also serve as a Clinical Advisor to the Centre for Aging + Brain Health Innovation (CABHI), the largest venture of its kind in the global seniors’ care sector.
He is an exceptionally prolific researcher in the area of dementia, serving since 2014 as Scientific Director of the Canadian Consortium on Neurodegeneration in Aging (CCNA), which has brought together 400 leading dementia researchers in Canada. Dr. Chertkow is an elected member of the Canadian Academy of Health Sciences.
His areas of research interest include: early diagnosis of Alzheimer’s disease and prediction of deterioration in individuals with mild cognitive impairment (MCI); the structure, organization, and function of the semantic memory component of long term memory, and its deterioration in dementia; localization of language and memory functions in the brain using functional imaging; and therapy of cognitive disorders in Alzheimer’s disease and frontotemporal dementia using neuromodulation approaches.
|Title||Source (Journal/Book/Conference)||Authors/Presenters||Published On||Type|
|Visual selective attention in mild cognitive impairment: Effects of task demands and auditory cues.||Journals of Gerontology: Psychological Sciences||McLaughlin P M, Anderson ND, Rich JB, Chertkow H, Murtha SJE||1377230400||Journal Article|
|Diagnosis and treatment of dementia: 5. Nonpharmacologic and pharmacologic therapy for mild to moderate dementia||Canadian Medical Association Journal||Hogan DB, Bailey P, Black S, Carswell A, Chertkow H, Clarke B, Cohen C, Fisk JD, Forbes D, Man-Son-Hing M, Lanctot K, Morgan D, Thorpe L||1225774800||Journal Article|
|Diagnosis and treatment of dementia: 4. Approach to management of mild to moderate dementia||Canadian Medical Association Journal||Hogan DB, Bailey P, Black S, Carswell A, Chertkow H, Clarke B, Cohen C, Fisk JD, Forbes D, Man-Son-Hing M, Lanctot K, Morgan D, Thorpe L||1223352000||Journal Article|
|Diagnosis and treatment of dementia: 3. Mild cognitive impairment and cognitive impairment without dementia||Canadian Medical Association Journal||Chertkow H, Massoud F, Nasreddine Z, Belleville S, Joanette Y, Bocti C, Drolet V, Kirk J, Freedman M, Bergman H||1210046400||Journal Article|
|Diagnosis and treatment of dementia: 2. Diagnosis||Canadian Medical Association Journal||Feldman HH, Jacova C, Robillard A, Garcia A, Chow T, Borrie M, Schipper HM, Blair M, Kertesz A, Chertkow H||1206417600||Journal Article|
|Mild cognitive impairment and cognitive impairment, no dementia: Part B, therapy||Alzheimer's & Dementia||Massoud F, Belleville S, Bergman H, Kirk J, Chertkow H, Nasreddine Z, Joanette Y, Freedman M||1191211200||Journal Article|
|Imaging biomarkers and their role in dementia clinical trials.||Canadian Journal of Neurological Sciences||Chertkow H, Black S||1167627600||Journal Article|
|Progress in clinical neurosciences: Canadian guidelines for the development of antidementia therapies: a conceptual summary||Canadian Journal of Neurological Sciences||Feldman HH, Gauthier S, Chertkow H, Conn DK, Freedman M, Chris M,||1136091600||Journal Article|
|A case study of pure word deafness: modularity in auditory processing?||Neurocase||Pinard M, Chertkow H, Black S, Peretz I||1009861200||Journal Article|